BRUSSELS - The European Commission on Thursday said it had fined five pharmaceutical companies for a total of 13.4 million euros in a settlement of an antitrust investigation.
The commission fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
U.S. Treasury bond ETFs draw net inflows this year despite recent market routExplore stories from Atlantic Canada.
ادامه مطلب »
Planemakers bet on steady demand for business jets, but Wall Street waryExplore stories from Atlantic Canada.
ادامه مطلب »
EU securities watchdog warns investors over crypto market protectionsExplore stories from Atlantic Canada.
ادامه مطلب »